tirzepatide surmount-1 percent weight loss 72 weeks after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Tirzepatide for maintenance of bodyweight

Presented for research literature review only Ceravolo R et al

On average, people lose 15% of their body weight on GLP-1 medication when they also make consistent lifestyle changes

This is one mechanism that contributes to weight loss with this class of medications people using them have a prolonged sense of satiety and greater portion control, Dr

We understand that selecting the most effective weight loss medication is a personal decision that requires expert guidance

Those who had these genetic issues had higher body mass index (BMI) and body mass on average, and were more likely to have type 1 diabetes and other metabolic issues

Why it matters: Cleaning the injection site and the vial top before every dose prevents infection and keeps everything hygienic